Nucleic acid testing to detect HBV infection in blood donors

New England Journal of Medicine

Volumn 364, Issue 3, 2011, Pages 236-247

  Stramer, Susan L ^a   Wend, Ulrike ^c   Candotti, Daniel ^d   Foster, Gregory A ^a   Hollinger, F Blaine ^e   Dodd, Roger Y ^b   Allain, Jean Pierre ^d   Gerlich, Wolfram ^c  

^a AMERICAN RED CROSS   (United States)

^b HOLLAND LABORATORY   (United States)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; NUCLEIC ACID; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOCHEMISTRY; BLOOD DONOR; FEMALE; FOLLOW UP; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; NUCLEIC ACID ANALYSIS; PRIORITY JOURNAL; SERODIAGNOSIS; SEROLOGY; SEXUAL TRANSMISSION; SEXUALITY; VIRUS DETECTION; VIRUS STRAIN;

EID: 78751612662     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1007644     Document Type: Article

References (33)

1. Hoofnagle JH, Seeff LB, Bales ZB, Zimmerman HJ. Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. N Engl J Med 1978;298:1379-83.
2. Mosley JW, Stevens CE, Aach RD, et al. Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients. Transfusion 1995;35:5-12.
3. Stevens CE, Aach RD, Hollinger FB, et al. Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients: an analysis of the Transfusion-Transmitted Viruses Study. Ann Intern Med 1984;101:733-8.
4. Mosley JW, Huang W, Stram DO, et al. Donor levels of serum alanine aminotransferase activity and antibody to hepatitis B core antigen associated with recipient hepatitis C and non-B, non-C outcomes. Transfusion 1996;36:776-81. [Erratum, Transfusion 1997;37:109.] (Pubitemid 26318181)
5. Raimondo G, Allain JP, Brunetto MR, et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 2008;49:652-7.
6. Hollinger FB. Hepatitis B virus infection and transfusion medicine: science and the occult. Transfusion 2008;48:1001-26.
7. Yoshikawa A, Gotanda Y, Minegishi K, et al. Lengths of hepatitis B viremia and antigenemia in blood donors: preliminary evidence of occult (HBsAg-negative) infection in the acute stage. Transfusion 2007;47:1162-71. (Pubitemid 46934305)
8. Manzini P, Abate ML, Valpreda C, et al. Evidence of acute primary occult hepatitis B virus infection in an Italian repeat blood donor. Transfusion 2009;49:757-64.
9. Bremer CM, Saniewski M, Wend UC, et al. Transient occult hepatitis B virus infection in a blood donor with high viremia. Transfusion 2009;49:1621-9.
10. Phikulsod S, Oota S, Tirawatnapong T, et al. One-year experience of nucleic acid technology testing for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations. Transfusion 2009;49:1126-35.
11. Satake M, Taira R, Yugi H, et al. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program. Transfusion 2007;47:1197-205. (Pubitemid 46934327)
12. Tabuchi A, Tanaka J, Katayama K, et al. Titration of hepatitis B virus infectivity in the sera of pre-acute and late acute phases of HBV infection: transmission experiments to chimeric mice with human liver repopulated hepatocytes. J Med Virol 2008;80:2064-8.
13. Zou S, Stramer SL, Notari EP, et al. Current incidence and residual risk of hepatitis B infection among blood donors in the United States. Transfusion 2009;49:1609-20.
14. Center for Biologics Evaluation and Research. Blood Products Advisory Committee, 94th Meeting, Gaithersburg, MD, April 1, 2009 (transcript). (http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/ BloodVaccinesandOtherBiologics/BloodProductsAdvisoryCommittee/UCM155628.pdf.)
15. Linauts S, Saldanha J, Strong DM. PRISM HBsAg detection of hepatitis B virus minipool nucleic acid testing yield samples. Transfusion 2008;48:1376-82.
16. O'Brien SF, Xi G, Fan W, et al. Epidemiology of hepatitis B in Canadian blood donors. Transfusion 2008;48:2323-30.
17. Daniels D, Grytdal S, Wasley A. Surveillance for acute viral hepatitis - United States, 2007. MMWR Surveill Summ 2009;58:1-27.
18. Zou S, Dorsey KA, Notari EP, et al. Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing. Transfusion 2010;50:1495-504.
19. Hollinger FB, Sood G. Occult hepatitis B virus infection: a covert operation. J Viral Hepat 2010;17:1-15. [Erratum, J Viral Hepat 2010;17:600.]
20. Aach RD, Alter HJ, Hollinger FB, et al. Risk of transfusing blood containing antibody to hepatitis-B surface antigen. Lancet 1974;2:190-3.
21. Prince AM, Lee DH, Brotman B. Infectivity of blood from PCR-positive, HBsAg-negative, anti-HBs-positive cases of resolved hepatitis B infection. Transfusion 2001;41:329-32. (Pubitemid 32238529)
22. Dreier J, Kröger M, Diekmann J, Götting C, Kleesiek K. Low-level viraemia of hepatitis B virus in an anti-HBc- and anti-HBs-positive blood donor. Transfus Med 2004;14:97-103. (Pubitemid 38623072)
23. Gerlich WH. Breakthrough of hepatitis B virus escape mutants after vaccination and virus reactivation. J Clin Virol 2006;36:Suppl 1:S18-S22.
24. Levicnik-Stezinar S, Rahne-Potokar U, Candotti D, Lelie N, Allain JP. Anti-HBs positive occult hepatitis B virus carrier blood infectious in two transfusion recipients. J Hepatol 2008;48:1022-5.
25. Stramer SL, Glynn SA, Kleinman SH, et al. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N Engl J Med 2004;351:760-8.
26. Jackson BR, Busch MP, Stramer SL, AuBuchon JP. The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations. Transfusion 2003;43:721-9.
27. Kleinman SH, Lelie N, Busch MP. Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion. Transfusion 2009;49:2454-89.
28. Delwart EL, Kalmin ND, Jones TS, et al. First report of human immunodeficiency virus transmission via an RNAscreened blood donation. Vox Sang 2004;86:171-7.
29. Phelps R, Robbins K, Liberti T, et al. Window-period human immunodeficiency virus transmission to two recipients by an adolescent blood donor. Transfusion 2004;44:929-33. (Pubitemid 38738425)
30. Stramer SL, Chambers L, Page PL, Wagner AG, Gibble J. Third reported US case of breakthrough HIV transmission from NAT screened blood. Transfusion 2003;43:Suppl:40A-41A. abstract.
31. Laffoon B, Crutchfield A, Levi M, et al. HIV transmission through transfusion - Missouri and Colorado, 2008. Morb Mortal Wkly Rpt 2010;59:1335-9.
32. Taylor C, Price TH, Strong DM. Possible HCV transmission from blood screened by pooled nucleic acid testing. Transfusion 2002;42:Suppl:9S. abstract.
33. Stramer SL, Hollinger FB, Katz LM, et al. Emerging infectious disease agents and their potential threat to transfusion safety. Transfusion 2009;49:Suppl 2:1S-29S.